nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP19A1—Paclitaxel—lung cancer	0.124	0.357	CbGbCtD
Danazol—CCL2—alveolus of lung—lung cancer	0.0514	0.465	CbGeAlD
Danazol—CYP3A4—Topotecan—lung cancer	0.0317	0.0913	CbGbCtD
Danazol—CYP3A4—Gefitinib—lung cancer	0.029	0.0835	CbGbCtD
Danazol—CYP3A4—Teniposide—lung cancer	0.0282	0.081	CbGbCtD
Danazol—CYP3A4—Vinorelbine—lung cancer	0.0224	0.0643	CbGbCtD
Danazol—CYP3A4—Crizotinib—lung cancer	0.0178	0.0512	CbGbCtD
Danazol—CYP3A4—Erlotinib—lung cancer	0.0172	0.0494	CbGbCtD
Danazol—CYP3A4—Paclitaxel—lung cancer	0.0157	0.0452	CbGbCtD
Danazol—CYP3A4—Irinotecan—lung cancer	0.0155	0.0446	CbGbCtD
Danazol—CYP3A4—Vinblastine—lung cancer	0.0138	0.0397	CbGbCtD
Danazol—CYP3A4—Etoposide—lung cancer	0.0124	0.0357	CbGbCtD
Danazol—CYP3A4—Docetaxel—lung cancer	0.0114	0.0327	CbGbCtD
Danazol—CYP3A4—Doxorubicin—lung cancer	0.00847	0.0244	CbGbCtD
Danazol—CCL2—respiratory system—lung cancer	0.00518	0.0469	CbGeAlD
Danazol—CCL2—epithelium—lung cancer	0.00433	0.0392	CbGeAlD
Danazol—CCL2—bronchus—lung cancer	0.00426	0.0386	CbGeAlD
Danazol—PGR—mammary gland—lung cancer	0.00408	0.037	CbGeAlD
Danazol—CCL2—trachea—lung cancer	0.00383	0.0346	CbGeAlD
Danazol—CCL2—cardiac atrium—lung cancer	0.00359	0.0325	CbGeAlD
Danazol—ESR1—mammary gland—lung cancer	0.00319	0.0289	CbGeAlD
Danazol—CCL2—bone marrow—lung cancer	0.00303	0.0275	CbGeAlD
Danazol—CCL2—lung—lung cancer	0.00275	0.0249	CbGeAlD
Danazol—PGR—respiratory system—lung cancer	0.00272	0.0246	CbGeAlD
Danazol—PGR—epithelium—lung cancer	0.00227	0.0206	CbGeAlD
Danazol—ESR1—respiratory system—lung cancer	0.00213	0.0193	CbGeAlD
Danazol—CCL2—lymph node—lung cancer	0.00188	0.017	CbGeAlD
Danazol—AR—epithelium—lung cancer	0.00181	0.0164	CbGeAlD
Danazol—AR—bronchus—lung cancer	0.00178	0.0162	CbGeAlD
Danazol—ESR1—epithelium—lung cancer	0.00178	0.0161	CbGeAlD
Danazol—SHBG—bone marrow—lung cancer	0.00177	0.016	CbGeAlD
Danazol—AR—cardiac atrium—lung cancer	0.0015	0.0136	CbGeAlD
Danazol—PGR—lung—lung cancer	0.00144	0.0131	CbGeAlD
Danazol—Hydrocortisone—ANXA1—lung cancer	0.00123	0.232	CrCbGaD
Danazol—AR—lung—lung cancer	0.00115	0.0104	CbGeAlD
Danazol—ESR1—lung—lung cancer	0.00113	0.0102	CbGeAlD
Danazol—Testosterone Propionate—UGT1A1—lung cancer	0.00107	0.201	CrCbGaD
Danazol—PGR—lymph node—lung cancer	0.000988	0.00895	CbGeAlD
Danazol—CYP19A1—lymph node—lung cancer	0.000889	0.00805	CbGeAlD
Danazol—AR—lymph node—lung cancer	0.000787	0.00713	CbGeAlD
Danazol—ESR1—lymph node—lung cancer	0.000773	0.007	CbGeAlD
Danazol—Hydrocortisone—ABCG2—lung cancer	0.000338	0.0636	CrCbGaD
Danazol—Progesterone—CYP2A6—lung cancer	0.000308	0.0579	CrCbGaD
Danazol—Shock—Irinotecan—lung cancer	0.000307	0.00108	CcSEcCtD
Danazol—Tension—Paclitaxel—lung cancer	0.000306	0.00108	CcSEcCtD
Danazol—Muscle spasms—Etoposide—lung cancer	0.000306	0.00108	CcSEcCtD
Danazol—Thrombocytopenia—Irinotecan—lung cancer	0.000306	0.00108	CcSEcCtD
Danazol—Haemoglobin—Docetaxel—lung cancer	0.000305	0.00108	CcSEcCtD
Danazol—Oedema—Gemcitabine—lung cancer	0.000304	0.00107	CcSEcCtD
Danazol—Haemorrhage—Docetaxel—lung cancer	0.000304	0.00107	CcSEcCtD
Danazol—Nervousness—Paclitaxel—lung cancer	0.000303	0.00107	CcSEcCtD
Danazol—Irritability—Methotrexate—lung cancer	0.000302	0.00106	CcSEcCtD
Danazol—Hyperhidrosis—Irinotecan—lung cancer	0.000302	0.00106	CcSEcCtD
Danazol—Back pain—Paclitaxel—lung cancer	0.000302	0.00106	CcSEcCtD
Danazol—Dizziness—Vinblastine—lung cancer	0.000301	0.00106	CcSEcCtD
Danazol—Convulsion—Cisplatin—lung cancer	0.000301	0.00106	CcSEcCtD
Danazol—Urticaria—Vinorelbine—lung cancer	0.000301	0.00106	CcSEcCtD
Danazol—Muscle spasms—Paclitaxel—lung cancer	0.0003	0.00106	CcSEcCtD
Danazol—Mood swings—Methotrexate—lung cancer	0.0003	0.00106	CcSEcCtD
Danazol—Body temperature increased—Vinorelbine—lung cancer	0.000299	0.00105	CcSEcCtD
Danazol—Thrombocytopenia—Gemcitabine—lung cancer	0.000298	0.00105	CcSEcCtD
Danazol—Anxiety—Cisplatin—lung cancer	0.000295	0.00104	CcSEcCtD
Danazol—Vision blurred—Paclitaxel—lung cancer	0.000294	0.00104	CcSEcCtD
Danazol—Hyperhidrosis—Gemcitabine—lung cancer	0.000294	0.00104	CcSEcCtD
Danazol—Visual impairment—Docetaxel—lung cancer	0.000293	0.00103	CcSEcCtD
Danazol—Dizziness—Topotecan—lung cancer	0.000293	0.00103	CcSEcCtD
Danazol—Tremor—Paclitaxel—lung cancer	0.000292	0.00103	CcSEcCtD
Danazol—Vomiting—Vinblastine—lung cancer	0.00029	0.00102	CcSEcCtD
Danazol—Dizziness—Erlotinib—lung cancer	0.000289	0.00102	CcSEcCtD
Danazol—Erythema multiforme—Docetaxel—lung cancer	0.000287	0.00101	CcSEcCtD
Danazol—Vertigo—Etoposide—lung cancer	0.000286	0.00101	CcSEcCtD
Danazol—Headache—Vinblastine—lung cancer	0.000285	0.00101	CcSEcCtD
Danazol—Leukopenia—Etoposide—lung cancer	0.000285	0.001	CcSEcCtD
Danazol—Oedema—Cisplatin—lung cancer	0.000283	0.000998	CcSEcCtD
Danazol—Flushing—Docetaxel—lung cancer	0.000282	0.000993	CcSEcCtD
Danazol—Vomiting—Topotecan—lung cancer	0.000281	0.000991	CcSEcCtD
Danazol—Paraesthesia—Irinotecan—lung cancer	0.00028	0.000987	CcSEcCtD
Danazol—Vertigo—Paclitaxel—lung cancer	0.00028	0.000987	CcSEcCtD
Danazol—Syncope—Paclitaxel—lung cancer	0.00028	0.000985	CcSEcCtD
Danazol—Loss of consciousness—Etoposide—lung cancer	0.00028	0.000985	CcSEcCtD
Danazol—Leukopenia—Paclitaxel—lung cancer	0.000279	0.000984	CcSEcCtD
Danazol—Rash—Topotecan—lung cancer	0.000279	0.000983	CcSEcCtD
Danazol—Dermatitis—Topotecan—lung cancer	0.000279	0.000982	CcSEcCtD
Danazol—Vomiting—Erlotinib—lung cancer	0.000278	0.00098	CcSEcCtD
Danazol—Thrombocytopenia—Cisplatin—lung cancer	0.000277	0.000977	CcSEcCtD
Danazol—Headache—Topotecan—lung cancer	0.000277	0.000976	CcSEcCtD
Danazol—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000277	0.000976	CcSEcCtD
Danazol—Tachycardia—Cisplatin—lung cancer	0.000277	0.000974	CcSEcCtD
Danazol—Rash—Erlotinib—lung cancer	0.000276	0.000972	CcSEcCtD
Danazol—Dermatitis—Erlotinib—lung cancer	0.000276	0.000971	CcSEcCtD
Danazol—Palpitations—Paclitaxel—lung cancer	0.000276	0.000971	CcSEcCtD
Danazol—Convulsion—Etoposide—lung cancer	0.000276	0.000971	CcSEcCtD
Danazol—Dyspepsia—Irinotecan—lung cancer	0.000275	0.000968	CcSEcCtD
Danazol—Hypertension—Etoposide—lung cancer	0.000275	0.000968	CcSEcCtD
Danazol—Headache—Erlotinib—lung cancer	0.000274	0.000966	CcSEcCtD
Danazol—Loss of consciousness—Paclitaxel—lung cancer	0.000274	0.000966	CcSEcCtD
Danazol—Hyperhidrosis—Cisplatin—lung cancer	0.000274	0.000965	CcSEcCtD
Danazol—Paraesthesia—Gemcitabine—lung cancer	0.000273	0.000962	CcSEcCtD
Danazol—Chills—Docetaxel—lung cancer	0.000272	0.00096	CcSEcCtD
Danazol—Asthenia—Vinorelbine—lung cancer	0.000271	0.000957	CcSEcCtD
Danazol—Eosinophilia—Methotrexate—lung cancer	0.000271	0.000954	CcSEcCtD
Danazol—Nausea—Vinblastine—lung cancer	0.00027	0.000953	CcSEcCtD
Danazol—Convulsion—Paclitaxel—lung cancer	0.00027	0.000952	CcSEcCtD
Danazol—Affect lability—Doxorubicin—lung cancer	0.00027	0.00095	CcSEcCtD
Danazol—Migraine—Doxorubicin—lung cancer	0.00027	0.00095	CcSEcCtD
Danazol—Hypertension—Paclitaxel—lung cancer	0.000269	0.000949	CcSEcCtD
Danazol—Fatigue—Irinotecan—lung cancer	0.000269	0.000948	CcSEcCtD
Danazol—Alopecia—Docetaxel—lung cancer	0.000268	0.000945	CcSEcCtD
Danazol—Pancreatitis—Methotrexate—lung cancer	0.000268	0.000945	CcSEcCtD
Danazol—Pruritus—Vinorelbine—lung cancer	0.000268	0.000943	CcSEcCtD
Danazol—Constipation—Irinotecan—lung cancer	0.000267	0.00094	CcSEcCtD
Danazol—Arthralgia—Paclitaxel—lung cancer	0.000266	0.000935	CcSEcCtD
Danazol—Anxiety—Paclitaxel—lung cancer	0.000265	0.000932	CcSEcCtD
Danazol—Nausea—Topotecan—lung cancer	0.000263	0.000926	CcSEcCtD
Danazol—Fatigue—Gemcitabine—lung cancer	0.000262	0.000923	CcSEcCtD
Danazol—Testosterone—ABCG2—lung cancer	0.00026	0.049	CrCbGaD
Danazol—Constipation—Gemcitabine—lung cancer	0.00026	0.000916	CcSEcCtD
Danazol—Nausea—Erlotinib—lung cancer	0.00026	0.000916	CcSEcCtD
Danazol—Mood swings—Doxorubicin—lung cancer	0.00026	0.000914	CcSEcCtD
Danazol—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000258	0.00091	CcSEcCtD
Danazol—Back pain—Docetaxel—lung cancer	0.000256	0.000901	CcSEcCtD
Danazol—Oedema—Paclitaxel—lung cancer	0.000255	0.000897	CcSEcCtD
Danazol—Paraesthesia—Cisplatin—lung cancer	0.000254	0.000896	CcSEcCtD
Danazol—Thrombocytopenia—Etoposide—lung cancer	0.000254	0.000896	CcSEcCtD
Danazol—Muscle spasms—Docetaxel—lung cancer	0.000254	0.000895	CcSEcCtD
Danazol—Tachycardia—Etoposide—lung cancer	0.000253	0.000893	CcSEcCtD
Danazol—Hyperhidrosis—Etoposide—lung cancer	0.000251	0.000884	CcSEcCtD
Danazol—Shock—Paclitaxel—lung cancer	0.00025	0.000882	CcSEcCtD
Danazol—Dizziness—Vinorelbine—lung cancer	0.00025	0.000882	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—lung cancer	0.00025	0.000882	CcSEcCtD
Danazol—Photosensitivity reaction—Methotrexate—lung cancer	0.00025	0.000879	CcSEcCtD
Danazol—Thrombocytopenia—Paclitaxel—lung cancer	0.000249	0.000878	CcSEcCtD
Danazol—Tachycardia—Paclitaxel—lung cancer	0.000248	0.000875	CcSEcCtD
Danazol—Body temperature increased—Irinotecan—lung cancer	0.000247	0.000869	CcSEcCtD
Danazol—Hyperhidrosis—Paclitaxel—lung cancer	0.000246	0.000867	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000242	0.000852	CcSEcCtD
Danazol—Vomiting—Vinorelbine—lung cancer	0.000241	0.000848	CcSEcCtD
Danazol—Body temperature increased—Gemcitabine—lung cancer	0.00024	0.000847	CcSEcCtD
Danazol—Rash—Vinorelbine—lung cancer	0.000239	0.000841	CcSEcCtD
Danazol—Dermatitis—Vinorelbine—lung cancer	0.000238	0.00084	CcSEcCtD
Danazol—Headache—Vinorelbine—lung cancer	0.000237	0.000835	CcSEcCtD
Danazol—Syncope—Docetaxel—lung cancer	0.000237	0.000835	CcSEcCtD
Danazol—Leukopenia—Docetaxel—lung cancer	0.000237	0.000834	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—lung cancer	0.000234	0.000826	CcSEcCtD
Danazol—Sweating—Methotrexate—lung cancer	0.000234	0.000823	CcSEcCtD
Danazol—Palpitations—Docetaxel—lung cancer	0.000234	0.000823	CcSEcCtD
Danazol—Paraesthesia—Etoposide—lung cancer	0.000233	0.000821	CcSEcCtD
Danazol—Haematuria—Methotrexate—lung cancer	0.000232	0.000819	CcSEcCtD
Danazol—Loss of consciousness—Docetaxel—lung cancer	0.000232	0.000819	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—lung cancer	0.000232	0.000818	CcSEcCtD
Danazol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000232	0.000817	CcSEcCtD
Danazol—Convulsion—Docetaxel—lung cancer	0.000229	0.000807	CcSEcCtD
Danazol—Paraesthesia—Paclitaxel—lung cancer	0.000229	0.000805	CcSEcCtD
Danazol—Hypertension—Docetaxel—lung cancer	0.000228	0.000804	CcSEcCtD
Danazol—Arthralgia—Docetaxel—lung cancer	0.000225	0.000793	CcSEcCtD
Danazol—Nausea—Vinorelbine—lung cancer	0.000225	0.000792	CcSEcCtD
Danazol—Dyspepsia—Paclitaxel—lung cancer	0.000224	0.000789	CcSEcCtD
Danazol—Body temperature increased—Cisplatin—lung cancer	0.000224	0.000789	CcSEcCtD
Danazol—Asthenia—Irinotecan—lung cancer	0.000224	0.000789	CcSEcCtD
Danazol—Fatigue—Etoposide—lung cancer	0.000224	0.000789	CcSEcCtD
Danazol—Constipation—Etoposide—lung cancer	0.000222	0.000782	CcSEcCtD
Danazol—Haemoglobin—Methotrexate—lung cancer	0.00022	0.000775	CcSEcCtD
Danazol—Fatigue—Paclitaxel—lung cancer	0.000219	0.000773	CcSEcCtD
Danazol—Haemorrhage—Methotrexate—lung cancer	0.000219	0.000771	CcSEcCtD
Danazol—Asthenia—Gemcitabine—lung cancer	0.000218	0.000768	CcSEcCtD
Danazol—Constipation—Paclitaxel—lung cancer	0.000218	0.000767	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—lung cancer	0.000216	0.000761	CcSEcCtD
Danazol—Oedema—Docetaxel—lung cancer	0.000216	0.00076	CcSEcCtD
Danazol—Progesterone—CYP1A1—lung cancer	0.000216	0.0406	CrCbGaD
Danazol—Weight increased—Doxorubicin—lung cancer	0.000215	0.000759	CcSEcCtD
Danazol—Pruritus—Gemcitabine—lung cancer	0.000215	0.000758	CcSEcCtD
Danazol—Shock—Docetaxel—lung cancer	0.000212	0.000748	CcSEcCtD
Danazol—Thrombocytopenia—Docetaxel—lung cancer	0.000211	0.000744	CcSEcCtD
Danazol—Visual impairment—Methotrexate—lung cancer	0.000211	0.000743	CcSEcCtD
Danazol—Tachycardia—Docetaxel—lung cancer	0.000211	0.000742	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000209	0.000737	CcSEcCtD
Danazol—Prednisone—ALB—lung cancer	0.000209	0.0394	CrCbGaD
Danazol—Erythema multiforme—Methotrexate—lung cancer	0.000207	0.000729	CcSEcCtD
Danazol—Dizziness—Irinotecan—lung cancer	0.000206	0.000727	CcSEcCtD
Danazol—Urticaria—Etoposide—lung cancer	0.000206	0.000727	CcSEcCtD
Danazol—Norethindrone—ALB—lung cancer	0.000206	0.0388	CrCbGaD
Danazol—Jaundice—Doxorubicin—lung cancer	0.000206	0.000725	CcSEcCtD
Danazol—Body temperature increased—Etoposide—lung cancer	0.000205	0.000723	CcSEcCtD
Danazol—Ethinyl Estradiol—ABCB1—lung cancer	0.000204	0.0385	CrCbGaD
Danazol—Testosterone—CYP1A1—lung cancer	0.000204	0.0384	CrCbGaD
Danazol—Asthenia—Cisplatin—lung cancer	0.000203	0.000716	CcSEcCtD
Danazol—Sweating—Doxorubicin—lung cancer	0.000202	0.000713	CcSEcCtD
Danazol—Urticaria—Paclitaxel—lung cancer	0.000202	0.000712	CcSEcCtD
Danazol—Haematuria—Doxorubicin—lung cancer	0.000201	0.000709	CcSEcCtD
Danazol—Body temperature increased—Paclitaxel—lung cancer	0.000201	0.000709	CcSEcCtD
Danazol—Prednisone—ABCB1—lung cancer	0.000199	0.0376	CrCbGaD
Danazol—Vomiting—Irinotecan—lung cancer	0.000198	0.000699	CcSEcCtD
Danazol—Rash—Irinotecan—lung cancer	0.000197	0.000693	CcSEcCtD
Danazol—Dermatitis—Irinotecan—lung cancer	0.000197	0.000693	CcSEcCtD
Danazol—Norethindrone—ABCB1—lung cancer	0.000197	0.037	CrCbGaD
Danazol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000197	0.000693	CcSEcCtD
Danazol—Chills—Methotrexate—lung cancer	0.000196	0.000692	CcSEcCtD
Danazol—Methyltestosterone—ALB—lung cancer	0.000196	0.0368	CrCbGaD
Danazol—Headache—Irinotecan—lung cancer	0.000196	0.000689	CcSEcCtD
Danazol—Paraesthesia—Docetaxel—lung cancer	0.000194	0.000683	CcSEcCtD
Danazol—Alopecia—Methotrexate—lung cancer	0.000193	0.000681	CcSEcCtD
Danazol—Vomiting—Gemcitabine—lung cancer	0.000193	0.000681	CcSEcCtD
Danazol—Rash—Gemcitabine—lung cancer	0.000192	0.000675	CcSEcCtD
Danazol—Dermatitis—Gemcitabine—lung cancer	0.000191	0.000675	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—lung cancer	0.00019	0.000671	CcSEcCtD
Danazol—Headache—Gemcitabine—lung cancer	0.00019	0.000671	CcSEcCtD
Danazol—Dyspepsia—Docetaxel—lung cancer	0.00019	0.000669	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—lung cancer	0.00019	0.000668	CcSEcCtD
Danazol—Asthenia—Etoposide—lung cancer	0.000186	0.000656	CcSEcCtD
Danazol—Fatigue—Docetaxel—lung cancer	0.000186	0.000655	CcSEcCtD
Danazol—Nausea—Irinotecan—lung cancer	0.000185	0.000653	CcSEcCtD
Danazol—Constipation—Docetaxel—lung cancer	0.000184	0.00065	CcSEcCtD
Danazol—Back pain—Methotrexate—lung cancer	0.000184	0.000649	CcSEcCtD
Danazol—Pruritus—Etoposide—lung cancer	0.000184	0.000647	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—lung cancer	0.000183	0.000643	CcSEcCtD
Danazol—Asthenia—Paclitaxel—lung cancer	0.000183	0.000643	CcSEcCtD
Danazol—Nausea—Gemcitabine—lung cancer	0.000181	0.000636	CcSEcCtD
Danazol—Vomiting—Cisplatin—lung cancer	0.00018	0.000635	CcSEcCtD
Danazol—Pruritus—Paclitaxel—lung cancer	0.00018	0.000634	CcSEcCtD
Danazol—Vision blurred—Methotrexate—lung cancer	0.00018	0.000633	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—lung cancer	0.000179	0.000631	CcSEcCtD
Danazol—Rash—Cisplatin—lung cancer	0.000179	0.000629	CcSEcCtD
Danazol—Dermatitis—Cisplatin—lung cancer	0.000178	0.000629	CcSEcCtD
Danazol—Flushing—Doxorubicin—lung cancer	0.000176	0.00062	CcSEcCtD
Danazol—Dizziness—Etoposide—lung cancer	0.000172	0.000605	CcSEcCtD
Danazol—Vertigo—Methotrexate—lung cancer	0.000171	0.000603	CcSEcCtD
Danazol—Body temperature increased—Docetaxel—lung cancer	0.000171	0.000601	CcSEcCtD
Danazol—Leukopenia—Methotrexate—lung cancer	0.000171	0.000601	CcSEcCtD
Danazol—Chills—Doxorubicin—lung cancer	0.00017	0.000599	CcSEcCtD
Danazol—Dizziness—Paclitaxel—lung cancer	0.000168	0.000593	CcSEcCtD
Danazol—Nausea—Cisplatin—lung cancer	0.000168	0.000593	CcSEcCtD
Danazol—Alopecia—Doxorubicin—lung cancer	0.000167	0.00059	CcSEcCtD
Danazol—Convulsion—Methotrexate—lung cancer	0.000165	0.000582	CcSEcCtD
Danazol—Vomiting—Etoposide—lung cancer	0.000165	0.000582	CcSEcCtD
Danazol—Rash—Etoposide—lung cancer	0.000164	0.000577	CcSEcCtD
Danazol—Dermatitis—Etoposide—lung cancer	0.000164	0.000576	CcSEcCtD
Danazol—Headache—Etoposide—lung cancer	0.000163	0.000573	CcSEcCtD
Danazol—Arthralgia—Methotrexate—lung cancer	0.000162	0.000571	CcSEcCtD
Danazol—Tension—Doxorubicin—lung cancer	0.000162	0.00057	CcSEcCtD
Danazol—Vomiting—Paclitaxel—lung cancer	0.000162	0.00057	CcSEcCtD
Danazol—Rash—Paclitaxel—lung cancer	0.00016	0.000565	CcSEcCtD
Danazol—Dermatitis—Paclitaxel—lung cancer	0.00016	0.000565	CcSEcCtD
Danazol—Nervousness—Doxorubicin—lung cancer	0.00016	0.000565	CcSEcCtD
Danazol—Back pain—Doxorubicin—lung cancer	0.00016	0.000562	CcSEcCtD
Danazol—Headache—Paclitaxel—lung cancer	0.000159	0.000562	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—lung cancer	0.000159	0.000559	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—lung cancer	0.000155	0.000548	CcSEcCtD
Danazol—Asthenia—Docetaxel—lung cancer	0.000155	0.000545	CcSEcCtD
Danazol—Nausea—Etoposide—lung cancer	0.000154	0.000543	CcSEcCtD
Danazol—Pruritus—Docetaxel—lung cancer	0.000153	0.000538	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—lung cancer	0.000152	0.000536	CcSEcCtD
Danazol—Nausea—Paclitaxel—lung cancer	0.000151	0.000533	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—lung cancer	0.00015	0.00053	CcSEcCtD
Danazol—Vertigo—Doxorubicin—lung cancer	0.000148	0.000522	CcSEcCtD
Danazol—Syncope—Doxorubicin—lung cancer	0.000148	0.000521	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—lung cancer	0.000148	0.00052	CcSEcCtD
Danazol—Palpitations—Doxorubicin—lung cancer	0.000146	0.000514	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—lung cancer	0.000145	0.000511	CcSEcCtD
Danazol—Convulsion—Doxorubicin—lung cancer	0.000143	0.000504	CcSEcCtD
Danazol—Dizziness—Docetaxel—lung cancer	0.000143	0.000503	CcSEcCtD
Danazol—Hypertension—Doxorubicin—lung cancer	0.000142	0.000502	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000142	0.000499	CcSEcCtD
Danazol—Hydrocortisone—ABCB1—lung cancer	0.000141	0.0265	CrCbGaD
Danazol—Arthralgia—Doxorubicin—lung cancer	0.00014	0.000495	CcSEcCtD
Danazol—Anxiety—Doxorubicin—lung cancer	0.00014	0.000493	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—lung cancer	0.00014	0.000492	CcSEcCtD
Danazol—Vomiting—Docetaxel—lung cancer	0.000137	0.000483	CcSEcCtD
Danazol—Dyspepsia—Methotrexate—lung cancer	0.000137	0.000482	CcSEcCtD
Danazol—Rash—Docetaxel—lung cancer	0.000136	0.000479	CcSEcCtD
Danazol—Dermatitis—Docetaxel—lung cancer	0.000136	0.000479	CcSEcCtD
Danazol—Headache—Docetaxel—lung cancer	0.000135	0.000476	CcSEcCtD
Danazol—Oedema—Doxorubicin—lung cancer	0.000135	0.000474	CcSEcCtD
Danazol—Fatigue—Methotrexate—lung cancer	0.000134	0.000472	CcSEcCtD
Danazol—Shock—Doxorubicin—lung cancer	0.000132	0.000467	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—lung cancer	0.000132	0.000464	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—lung cancer	0.000131	0.000463	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—lung cancer	0.00013	0.000459	CcSEcCtD
Danazol—Nausea—Docetaxel—lung cancer	0.000128	0.000451	CcSEcCtD
Danazol—Urticaria—Methotrexate—lung cancer	0.000124	0.000435	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—lung cancer	0.000123	0.000433	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000123	0.000432	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—lung cancer	0.000121	0.000426	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—lung cancer	0.000119	0.000418	CcSEcCtD
Danazol—Fatigue—Doxorubicin—lung cancer	0.000116	0.000409	CcSEcCtD
Danazol—Constipation—Doxorubicin—lung cancer	0.000115	0.000406	CcSEcCtD
Danazol—Progesterone—ABCB1—lung cancer	0.000115	0.0216	CrCbGaD
Danazol—Testosterone—ALB—lung cancer	0.000113	0.0214	CrCbGaD
Danazol—Asthenia—Methotrexate—lung cancer	0.000112	0.000393	CcSEcCtD
Danazol—Pruritus—Methotrexate—lung cancer	0.00011	0.000388	CcSEcCtD
Danazol—Testosterone—ABCB1—lung cancer	0.000108	0.0204	CrCbGaD
Danazol—Urticaria—Doxorubicin—lung cancer	0.000107	0.000377	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—lung cancer	0.000106	0.000375	CcSEcCtD
Danazol—Dizziness—Methotrexate—lung cancer	0.000103	0.000362	CcSEcCtD
Danazol—Vomiting—Methotrexate—lung cancer	9.89e-05	0.000348	CcSEcCtD
Danazol—Rash—Methotrexate—lung cancer	9.8e-05	0.000345	CcSEcCtD
Danazol—Dermatitis—Methotrexate—lung cancer	9.79e-05	0.000345	CcSEcCtD
Danazol—Headache—Methotrexate—lung cancer	9.74e-05	0.000343	CcSEcCtD
Danazol—Asthenia—Doxorubicin—lung cancer	9.66e-05	0.00034	CcSEcCtD
Danazol—Pruritus—Doxorubicin—lung cancer	9.53e-05	0.000336	CcSEcCtD
Danazol—Nausea—Methotrexate—lung cancer	9.24e-05	0.000325	CcSEcCtD
Danazol—Dizziness—Doxorubicin—lung cancer	8.9e-05	0.000314	CcSEcCtD
Danazol—Vomiting—Doxorubicin—lung cancer	8.56e-05	0.000302	CcSEcCtD
Danazol—Rash—Doxorubicin—lung cancer	8.49e-05	0.000299	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—lung cancer	8.48e-05	0.000299	CcSEcCtD
Danazol—Headache—Doxorubicin—lung cancer	8.43e-05	0.000297	CcSEcCtD
Danazol—Nausea—Doxorubicin—lung cancer	8e-05	0.000282	CcSEcCtD
Danazol—CCL2—Signaling Pathways—PIK3CB—lung cancer	2.62e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADCY1—lung cancer	2.57e-05	0.000102	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ATP5H—lung cancer	2.52e-05	9.95e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—lung cancer	2.52e-05	9.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—lung cancer	2.51e-05	9.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP2R1B—lung cancer	2.51e-05	9.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMARCA4—lung cancer	2.51e-05	9.91e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—lung cancer	2.5e-05	9.88e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—lung cancer	2.47e-05	9.77e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MDM2—lung cancer	2.46e-05	9.73e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RAF1—lung cancer	2.45e-05	9.7e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—STK11—lung cancer	2.45e-05	9.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB3—lung cancer	2.44e-05	9.65e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB2—lung cancer	2.43e-05	9.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HSPB1—lung cancer	2.42e-05	9.56e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—lung cancer	2.41e-05	9.52e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—lung cancer	2.4e-05	9.51e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CB—lung cancer	2.39e-05	9.47e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MTOR—lung cancer	2.39e-05	9.47e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—lung cancer	2.39e-05	9.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTHLH—lung cancer	2.39e-05	9.45e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—lung cancer	2.34e-05	9.27e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TERT—lung cancer	2.34e-05	9.25e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—lung cancer	2.34e-05	9.25e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—lung cancer	2.3e-05	9.1e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.3e-05	9.08e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—lung cancer	2.29e-05	9.04e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—lung cancer	2.28e-05	9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGFR1—lung cancer	2.27e-05	8.98e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—lung cancer	2.27e-05	8.96e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—lung cancer	2.26e-05	8.95e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—lung cancer	2.26e-05	8.94e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ERCC2—lung cancer	2.25e-05	8.9e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ANXA1—lung cancer	2.25e-05	8.88e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLBD1—lung cancer	2.24e-05	8.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIF1A—lung cancer	2.24e-05	8.84e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—lung cancer	2.22e-05	8.79e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—lung cancer	2.21e-05	8.73e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAT—lung cancer	2.2e-05	8.71e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—lung cancer	2.2e-05	8.71e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—lung cancer	2.2e-05	8.69e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.19e-05	8.66e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—lung cancer	2.19e-05	8.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FLT1—lung cancer	2.18e-05	8.6e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOA1—lung cancer	2.16e-05	8.53e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—lung cancer	2.16e-05	8.53e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—lung cancer	2.14e-05	8.48e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—lung cancer	2.14e-05	8.47e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—CREBBP—lung cancer	2.14e-05	8.46e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—lung cancer	2.14e-05	8.46e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—lung cancer	2.14e-05	8.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APP—lung cancer	2.13e-05	8.42e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH3—lung cancer	2.13e-05	8.42e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF9—lung cancer	2.11e-05	8.35e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—lung cancer	2.1e-05	8.32e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—lung cancer	2.1e-05	8.29e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—lung cancer	2.08e-05	8.23e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—lung cancer	2.08e-05	8.23e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—lung cancer	2.07e-05	8.2e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—lung cancer	2.07e-05	8.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD17B10—lung cancer	2.05e-05	8.11e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—lung cancer	2.04e-05	8.08e-05	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—lung cancer	2.03e-05	8.04e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—lung cancer	2.02e-05	8e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—lung cancer	2.02e-05	7.98e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—lung cancer	2.02e-05	7.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUNB—lung cancer	2.02e-05	7.98e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—lung cancer	1.97e-05	7.8e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—lung cancer	1.97e-05	7.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—lung cancer	1.97e-05	7.79e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—lung cancer	1.97e-05	7.79e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KIT—lung cancer	1.97e-05	7.79e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ERCC2—lung cancer	1.96e-05	7.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGF—lung cancer	1.95e-05	7.7e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK3—lung cancer	1.93e-05	7.64e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—lung cancer	1.92e-05	7.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CKB—lung cancer	1.91e-05	7.54e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—lung cancer	1.88e-05	7.43e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—lung cancer	1.88e-05	7.42e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—lung cancer	1.87e-05	7.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—lung cancer	1.85e-05	7.32e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—lung cancer	1.85e-05	7.32e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—lung cancer	1.85e-05	7.3e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—lung cancer	1.84e-05	7.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STK11—lung cancer	1.83e-05	7.24e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6R—lung cancer	1.83e-05	7.23e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREBBP—lung cancer	1.83e-05	7.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CNDP2—lung cancer	1.79e-05	7.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM2—lung cancer	1.79e-05	7.09e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK3—lung cancer	1.77e-05	6.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO3—lung cancer	1.77e-05	6.99e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTMR3—lung cancer	1.74e-05	6.9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAP2K1—lung cancer	1.74e-05	6.89e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—lung cancer	1.74e-05	6.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—lung cancer	1.73e-05	6.85e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—lung cancer	1.72e-05	6.8e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK3—lung cancer	1.71e-05	6.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PGAM1—lung cancer	1.7e-05	6.72e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOA1—lung cancer	1.69e-05	6.69e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—lung cancer	1.68e-05	6.65e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—lung cancer	1.67e-05	6.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AVP—lung cancer	1.66e-05	6.55e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CREBBP—lung cancer	1.65e-05	6.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A7—lung cancer	1.62e-05	6.41e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.62e-05	6.41e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—lung cancer	1.6e-05	6.31e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—lung cancer	1.59e-05	6.3e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—lung cancer	1.59e-05	6.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDC4—lung cancer	1.59e-05	6.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HES1—lung cancer	1.57e-05	6.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MDM2—lung cancer	1.55e-05	6.14e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RAF1—lung cancer	1.55e-05	6.11e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—lung cancer	1.54e-05	6.11e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—lung cancer	1.54e-05	6.1e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB2—lung cancer	1.53e-05	6.05e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—lung cancer	1.51e-05	5.97e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—lung cancer	1.51e-05	5.97e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—lung cancer	1.48e-05	5.84e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—lung cancer	1.47e-05	5.81e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—lung cancer	1.46e-05	5.77e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—lung cancer	1.45e-05	5.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RRM1—lung cancer	1.45e-05	5.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA3—lung cancer	1.45e-05	5.72e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CREBBP—lung cancer	1.43e-05	5.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB3—lung cancer	1.43e-05	5.66e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—lung cancer	1.41e-05	5.59e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—lung cancer	1.41e-05	5.58e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—lung cancer	1.39e-05	5.49e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—lung cancer	1.39e-05	5.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—lung cancer	1.37e-05	5.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—B4GALT5—lung cancer	1.36e-05	5.37e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—lung cancer	1.36e-05	5.37e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—lung cancer	1.35e-05	5.34e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—lung cancer	1.35e-05	5.34e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—lung cancer	1.35e-05	5.33e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—lung cancer	1.34e-05	5.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR1—lung cancer	1.33e-05	5.27e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA4—lung cancer	1.32e-05	5.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—lung cancer	1.31e-05	5.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—lung cancer	1.31e-05	5.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—lung cancer	1.31e-05	5.17e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK3—lung cancer	1.31e-05	5.16e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—lung cancer	1.3e-05	5.16e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—lung cancer	1.3e-05	5.15e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—lung cancer	1.29e-05	5.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA2—lung cancer	1.29e-05	5.1e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—lung cancer	1.27e-05	5.02e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOA1—lung cancer	1.27e-05	5.01e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—lung cancer	1.26e-05	4.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—lung cancer	1.24e-05	4.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA1—lung cancer	1.24e-05	4.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCC3—lung cancer	1.23e-05	4.86e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—lung cancer	1.21e-05	4.78e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—lung cancer	1.19e-05	4.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C1—lung cancer	1.19e-05	4.71e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—lung cancer	1.18e-05	4.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—lung cancer	1.18e-05	4.66e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—lung cancer	1.17e-05	4.64e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—lung cancer	1.17e-05	4.61e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—lung cancer	1.16e-05	4.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KIT—lung cancer	1.16e-05	4.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—lung cancer	1.16e-05	4.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—lung cancer	1.16e-05	4.57e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—lung cancer	1.16e-05	4.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UGT1A1—lung cancer	1.16e-05	4.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGF—lung cancer	1.14e-05	4.52e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK3—lung cancer	1.11e-05	4.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNG11—lung cancer	1.11e-05	4.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—lung cancer	1.1e-05	4.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—lung cancer	1.09e-05	4.3e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—lung cancer	1.08e-05	4.29e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6R—lung cancer	1.07e-05	4.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREBBP—lung cancer	1.07e-05	4.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDOA—lung cancer	1.06e-05	4.2e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—lung cancer	1.06e-05	4.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA3—lung cancer	1.03e-05	4.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAP2K1—lung cancer	1.02e-05	4.05e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—lung cancer	1.02e-05	4.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—lung cancer	1.02e-05	4.02e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK3—lung cancer	1.01e-05	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCG2—lung cancer	1e-05	3.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADCY1—lung cancer	1e-05	3.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—lung cancer	1e-05	3.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HPGDS—lung cancer	9.83e-06	3.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO2—lung cancer	9.83e-06	3.89e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—lung cancer	9.79e-06	3.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPP2R1B—lung cancer	9.77e-06	3.86e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—lung cancer	9.75e-06	3.86e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—lung cancer	9.53e-06	3.77e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCLC—lung cancer	9.42e-06	3.73e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2A6—lung cancer	9.42e-06	3.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—lung cancer	9.2e-06	3.64e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MDM2—lung cancer	9.11e-06	3.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RAF1—lung cancer	9.08e-06	3.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB2—lung cancer	8.98e-06	3.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO1—lung cancer	8.93e-06	3.53e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—lung cancer	8.9e-06	3.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—lung cancer	8.86e-06	3.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—lung cancer	8.86e-06	3.5e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—lung cancer	8.81e-06	3.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—lung cancer	8.52e-06	3.37e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—lung cancer	8.52e-06	3.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—lung cancer	8.15e-06	3.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—lung cancer	8.15e-06	3.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—lung cancer	8.14e-06	3.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—lung cancer	8.01e-06	3.17e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—lung cancer	7.93e-06	3.14e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NQO1—lung cancer	7.92e-06	3.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—lung cancer	7.92e-06	3.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—lung cancer	7.7e-06	3.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—lung cancer	7.67e-06	3.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—lung cancer	7.66e-06	3.03e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—lung cancer	7.52e-06	2.97e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—lung cancer	7.3e-06	2.89e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—lung cancer	7.22e-06	2.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STK11—lung cancer	7.14e-06	2.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—lung cancer	7.1e-06	2.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—lung cancer	6.92e-06	2.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—lung cancer	6.85e-06	2.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—lung cancer	6.83e-06	2.7e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—lung cancer	6.79e-06	2.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—lung cancer	6.61e-06	2.61e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK3—lung cancer	6.54e-06	2.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAT—lung cancer	6.43e-06	2.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—lung cancer	6.36e-06	2.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—lung cancer	6.25e-06	2.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—lung cancer	6.22e-06	2.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—lung cancer	6.14e-06	2.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—lung cancer	6.07e-06	2.4e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—lung cancer	5.89e-06	2.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—lung cancer	5.88e-06	2.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—lung cancer	5.76e-06	2.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ERCC2—lung cancer	5.71e-06	2.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—lung cancer	5.4e-06	2.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—lung cancer	5.23e-06	2.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—lung cancer	5e-06	1.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOA1—lung cancer	4.94e-06	1.95e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—lung cancer	4.78e-06	1.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—lung cancer	4.51e-06	1.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—lung cancer	4.41e-06	1.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—lung cancer	4.29e-06	1.7e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CREBBP—lung cancer	4.18e-06	1.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—lung cancer	3.96e-06	1.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—lung cancer	3.91e-06	1.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—lung cancer	3.45e-06	1.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—lung cancer	3.42e-06	1.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—lung cancer	2.99e-06	1.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—lung cancer	2.85e-06	1.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—lung cancer	2.11e-06	8.33e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—lung cancer	1.72e-06	6.8e-06	CbGpPWpGaD
